Biotricity (BTCY) update

On 12/17 I wrote:

It is a startup in the remote medical monitoring business waiting for FDA approval of its first product which should happen any day now and which is probably the reason for the current run-up.

The following day (12/18) Biotricity announced the FDA 510(k) Clearance

Biotricity Achieves FDA 510(k) Clearance for its Bioflux Device
GlobeNewswire December 18, 2017

REDWOOD CITY, Calif., Dec. 18, 2017 (GLOBE NEWSWIRE) – Biotricity Inc. (OTCQB:BTCY), a medical diagnostic and consumer healthcare technology company dedicated to delivering innovative, biometric remote monitoring solutions, has received its 510(k) clearance for its Bioflux device with the U.S. Food and Drug Administration (FDA). This latest 510(k) is the final FDA requirement needed for Biotricity to bring to market Bioflux in the US.

https://finance.yahoo.com/news/biotricity-achieves-fda-510-k…

On 12/22 Biotricity announced that it had receive financing to launch “Bioflux”

Biotricity Closes a Registered Direct Financing and Paves the Way for Bioflux Launch
GlobeNewswire December 22, 2017

REDWOOD CITY, Calif., Dec. 22, 2017 (GLOBE NEWSWIRE) – Biotricity Inc. (BTCY), a medical diagnostic and consumer healthcare technology company dedicated to delivering innovative, biometric remote monitoring solutions, today announced the entry into agreements and closing relating to the sale of 450,164 shares of its common stock at an offering price of $5.50 per share. The gross proceeds from the offering will be approximately $2.5M before deducting estimated offering expenses. The shares of common stock have been sold to existing investors of the Company.

https://finance.yahoo.com/news/biotricity-closes-registered-…

I’ve been taking advantage of the crazy volatility of the stock to lower my cost basis and to add to the position.

Denny Schlesinger

1 Like